Bruker Statistics
Total Valuation
Bruker has a market cap or net worth of $4.91 billion. The enterprise value is $7.29 billion.
| Market Cap | 4.91B |
| Enterprise Value | 7.29B |
Important Dates
The last earnings date was Monday, August 4, 2025, before market open.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | Jun 16, 2025 |
Share Statistics
Bruker has 151.72 million shares outstanding. The number of shares has increased by 3.40% in one year.
| Current Share Class | 151.72M |
| Shares Outstanding | 151.72M |
| Shares Change (YoY) | +3.40% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | 31.94% |
| Owned by Institutions (%) | 78.20% |
| Float | 103.18M |
Valuation Ratios
The trailing PE ratio is 62.14 and the forward PE ratio is 14.94.
| PE Ratio | 62.14 |
| Forward PE | 14.94 |
| PS Ratio | 1.43 |
| Forward PS | 1.33 |
| PB Ratio | 2.72 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 99.59 |
| P/OCF Ratio | 29.59 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.07, with an EV/FCF ratio of 147.84.
| EV / Earnings | 91.56 |
| EV / Sales | 2.12 |
| EV / EBITDA | 13.07 |
| EV / EBIT | 20.99 |
| EV / FCF | 147.84 |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 1.33.
| Current Ratio | 1.61 |
| Quick Ratio | 0.62 |
| Debt / Equity | 1.33 |
| Debt / EBITDA | 4.44 |
| Debt / FCF | 50.27 |
| Interest Coverage | 6.20 |
Financial Efficiency
Return on equity (ROE) is 4.07% and return on invested capital (ROIC) is 5.13%.
| Return on Equity (ROE) | 4.07% |
| Return on Assets (ROA) | 3.55% |
| Return on Invested Capital (ROIC) | 5.13% |
| Return on Capital Employed (ROCE) | 6.95% |
| Revenue Per Employee | $302,106 |
| Profits Per Employee | $6,985 |
| Employee Count | 11,396 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 1.47 |
Taxes
In the past 12 months, Bruker has paid $61.10 million in taxes.
| Income Tax | 61.10M |
| Effective Tax Rate | 44.83% |
Stock Price Statistics
The stock price has decreased by -47.81% in the last 52 weeks. The beta is 1.16, so Bruker's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | -47.81% |
| 50-Day Moving Average | 39.10 |
| 200-Day Moving Average | 47.23 |
| Relative Strength Index (RSI) | 36.92 |
| Average Volume (20 Days) | 4,115,883 |
Short Selling Information
The latest short interest is 9.33 million, so 6.15% of the outstanding shares have been sold short.
| Short Interest | 9.33M |
| Short Previous Month | 9.45M |
| Short % of Shares Out | 6.15% |
| Short % of Float | 9.04% |
| Short Ratio (days to cover) | 2.96 |
Income Statement
In the last 12 months, Bruker had revenue of $3.44 billion and earned $79.60 million in profits. Earnings per share was $0.52.
| Revenue | 3.44B |
| Gross Profit | 1.69B |
| Operating Income | 347.20M |
| Pretax Income | 455.90M |
| Net Income | 79.60M |
| EBITDA | 557.60M |
| EBIT | 347.20M |
| Earnings Per Share (EPS) | $0.52 |
Balance Sheet
The company has $99.30 million in cash and $2.48 billion in debt, giving a net cash position of -$2.38 billion or -$15.68 per share.
| Cash & Cash Equivalents | 99.30M |
| Total Debt | 2.48B |
| Net Cash | -2.38B |
| Net Cash Per Share | -$15.68 |
| Equity (Book Value) | 1.87B |
| Book Value Per Share | 11.89 |
| Working Capital | 815.30M |
Cash Flow
In the last 12 months, operating cash flow was $165.90 million and capital expenditures -$116.60 million, giving a free cash flow of $49.30 million.
| Operating Cash Flow | 165.90M |
| Capital Expenditures | -116.60M |
| Free Cash Flow | 49.30M |
| FCF Per Share | $0.32 |
Margins
Gross margin is 48.99%, with operating and profit margins of 10.08% and 2.31%.
| Gross Margin | 48.99% |
| Operating Margin | 10.08% |
| Pretax Margin | 3.96% |
| Profit Margin | 2.31% |
| EBITDA Margin | 16.20% |
| EBIT Margin | 10.08% |
| FCF Margin | 1.43% |
Dividends & Yields
This stock pays an annual dividend of $0.20, which amounts to a dividend yield of 0.62%.
| Dividend Per Share | $0.20 |
| Dividend Yield | 0.62% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 38.40% |
| Buyback Yield | -3.40% |
| Shareholder Yield | -2.79% |
| Earnings Yield | 1.62% |
| FCF Yield | 1.00% |
Analyst Forecast
The average price target for Bruker is $50.00, which is 54.51% higher than the current price. The consensus rating is "Buy".
| Price Target | $50.00 |
| Price Target Difference | 54.51% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 5.42% |
| EPS Growth Forecast (5Y) | 39.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bruker has an Altman Z-Score of 2.5 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.5 |
| Piotroski F-Score | 4 |